AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 06/01/2020 at 10:25 am #5350
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster

    AveXis, a Novartis Company, agrees to contribute the use of its gene therapy manufacturing expertise to help produce and scale novel vaccine that uses adeno-associated virus (AAV) vector for clinical trials.

    Learn more.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.